同卵双生子临床前阿尔茨海默病的起病研究
该研究在96对认知完好的老年同卵双生子中,分析脑脊液Aβ1-42/1-40比值、Aβ PET及Aβ生成标志物与tau的关系。结果显示Aβ生成标志物与总tau强相关,Aβ聚集标志物与p-tau中度相关;遗传/共享环境背景对Aβ和tau升高均有实质贡献,提示调节环境风险因素可能有助于延迟AD病理进程。
要点
- Aβ生成标志物与总tau在同卵双生子内强相关(r=0.73-0.86,p<0.0001)。
- Aβ聚集标志物与p-tau中度相关(r=0.50-0.64,p<0.0001)。
- 遗传/共享环境背景对Aβ和tau升高均有实质贡献。
核心结论
- 遗传/共享环境背景对Aβ和tau升高均有实质贡献,提示调节环境风险因素可能有助于延迟AD病理进程。
研究设计与样本
- 研究纳入96对认知完好的老年同卵双生子,采用广义估计方程(含双生子随机效应)分析标志物关联,并校正年龄、性别和APOE ε4基因型。
- 脑脊液Aβ1-42/1-40比值样本量n=126,Aβ PET样本量n=194。
主要发现
- 双生子内Aβ生成标志物与总tau强相关(r范围0.73-0.86,均p<0.0001)。
- 双生子内Aβ聚集标志物与p-tau中度相关(r范围0.50-0.64,均p<0.0001)。
- 双生子内Aβ生成标志物差异与tau水平差异相关(r范围0.49-0.61,均p<0.0001)。
临床怎么用
- 在临床前AD阶段,Aβ生成与tau水平呈协同升高,提示二者可作为早期病理进程的监测标志。
- 遗传/共享环境背景显著影响Aβ和tau升高,支持针对环境风险因素的干预可能延迟AD病理起病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The present work was undertaken to study the genetic contribution to the start of Alzheimer's disease (AD) with amyloid and tau biomarkers in cognitively intact older identical twins. METHODS: We studied in 96 monozygotic twin-pairs relationships between amyloid-beta (Aβ) aggregation as measured by the Aβ1-42/1-40 ratio in cerebrospinal fluid (CSF; n = 126) and positron emission tomography (PET, n = 194), and CSF markers for Aβ production (beta-secretase 1, Aβ1-40, and Aβ1-38) and CSF tau. Associations among markers were tested with generalized estimating equations including a random effect for twin status, adjusted for age, gender, and apolipoprotein E ε4 genotype. We used twin analyses to determine relative contributions of genetic and/or environmental factors to AD pathophysiological processes. RESULTS: Twenty-seven individuals (14%) had an abnormal amyloid PET, and 14 twin-pairs (15%) showed discordant amyloid PET scans. Within twin-pairs, Aβ production markers and total-tau (t-tau) levels strongly correlated (r range = 0.73-0.86, all p < 0.0001), and Aβ aggregation markers and 181-phosphorylated-tau (p-tau) levels correlated moderately strongly (r range = 0.50-0.64, all p < 0.0001). Cross-twin cross-trait analysis showed that Aβ1-38 in one twin correlated with Aβ1-42/1-40 ratios, and t-tau and p-tau levels in their cotwins (r range = -0.28 to 0.58, all p < .007). Within-pair differences in Aβ production markers related to differences in tau levels (r range = 0.49-0.61, all p < 0.0001). Twin discordance analyses suggest that Aβ production and tau levels show coordinated increases in very early AD. INTERPRETATION: Our results suggest a substantial genetic/shared environmental background contributes to both Aβ and tau increases, suggesting that modulation of environmental risk factors may aid in delaying the onset of AD pathophysiological processes. ANN NEUROL 2021;89:987-1000.
引用
- Konijnenberg E, Tomassen J, den Braber A, et al. Onset of Preclinical Alzheimer Disease in Monozygotic Twins. Ann Neurol. 2021. PMID: 33583080. doi:10.1002/ana.26048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。